Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001243235 | SCV001416379 | likely benign | Intellectual disability, CASK-related, X-linked | 2024-04-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002473240 | SCV002769969 | uncertain significance | not provided | 2022-12-18 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004034745 | SCV004919416 | uncertain significance | Inborn genetic diseases | 2023-10-10 | criteria provided, single submitter | clinical testing | The c.2395G>A (p.E799K) alteration is located in exon 25 (coding exon 25) of the CASK gene. This alteration results from a G to A substitution at nucleotide position 2395, causing the glutamic acid (E) at amino acid position 799 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |